General guidelines:

• Interpretation must be based first on morphology, and second on enhancement pattern, if morphologically indeterminant.

• Enhancement characteristics alone are not reliable.

• The associated mammographic and ultrasound findings must also be considered.

• When findings are discordant, the most suspicious finding should guide clinical decision making

Biopsy recommended if any of the following are present:

• Suspicious morphology

• Suspicious enhancement (Kuhl type II or III curve)

• Suspicious on ultrasound or mammography

Follow-up recommended if:

• Benign morphology and

• Probably benign enhancement (Kuhl type I curve) and

• Benign appearance on ultrasound and/or mammography